🔎 Trials Near Me

Utama › Fibrilasi Atrium › Alabama

Kajian klinikal Fibrilasi Atrium di Alabama

11 kajian untuk Fibrilasi Atrium sedang mencari peserta di lokasi di Alabama.

Bandar di Alabama

Teks kajian rasmi (Bahasa Inggeris)

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Advanced Cardiovascular, Alexander City
  • SEC Clinical Research, Dothan
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07626411

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • SEC Clinical Research, Dothan
  • Eastern Shore Research Institute, Fairhope
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07175428

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

  • Grandview Medical Center, Birmingham
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07527299

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

  • University of Alabama at Birmingham, Birmingham
  • Grandview Medical Center, Birmingham
  • Cardiology Associates of Mobile, Mobile
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04088071

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  • SEC Clinical Research, Dothan
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07430956

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

  • University of Alabama at Birmingham (UAB) Hospital, Birmingham
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT07298473

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

  • Grandview, Birmingham
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06784466

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  • Anthos Investigative Site 1040, Birmingham
  • Anthos Investigational site 9939, Birmingham
  • Anthos Investigative Site 9947, Birmingham
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 65 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05712200

Tracking Results of Ablations to Combat AF Registry Generation 2

  • Huntsville Hospital, Huntsville
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT05111015

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  • University of Alabama Hospital, Birmingham
  • University of South Alabama University Hospital, Mobile
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2026 · NCT03907046

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

  • Arrhythmia Institute at Grandview, Birmingham
  • Mobile Cardiology Associates, Mobile
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Okt 2025 · NCT06324201

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.